1-17 of 17
Authors: Go Kimura
Journal Article
First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia Open Access
Japanese Journal of Clinical Oncology, Volume 55, Issue 4, April 2025, Pages 406–413, https://doi.org/10.1093/jjco/hyae182
Published: 16 January 2025
Journal Article
Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial Open Access
Japanese Journal of Clinical Oncology, Volume 53, Issue 1, January 2023, Pages 16–25, https://doi.org/10.1093/jjco/hyac155
Published: 26 October 2022
Journal Article
Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association Free
Japanese Journal of Clinical Oncology, Volume 52, Issue 3, March 2022, Pages 274–280, https://doi.org/10.1093/jjco/hyab201
Published: 06 January 2022
Journal Article
Erratum to: Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma Open Access
Japanese Journal of Clinical Oncology, Volume 51, Issue 12, December 2021, Page 1770, https://doi.org/10.1093/jjco/hyab161
Published: 29 September 2021
Journal Article
Subgroup analysis of the AFTER I-O study: a retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma Open Access
Japanese Journal of Clinical Oncology, Volume 51, Issue 11, November 2021, Pages 1656–1664, https://doi.org/10.1093/jjco/hyab114
Published: 04 August 2021
Journal Article
Efficacy and safety of subsequent molecular targeted therapy after immuno-checkpoint therapy, retrospective study of Japanese patients with metastatic renal cell carcinoma (AFTER I-O study) Open Access
Japanese Journal of Clinical Oncology, Volume 51, Issue 6, June 2021, Pages 966–975, https://doi.org/10.1093/jjco/hyaa266
Published: 17 February 2021
Journal Article
Difficulty in differential diagnosis for renal cancer with microscopic papillary architecture: overlapped pathological features among papillary renal cell carcinoma (RCC), mutinous tubular and spindle cell carcinoma, and unclassified RCC. Lessons from a Japanese multicenter study Free
Japanese Journal of Clinical Oncology, Volume 50, Issue 11, November 2020, Pages 1313–1320, https://doi.org/10.1093/jjco/hyaa114
Published: 13 July 2020
Journal Article
Corrigendum to: Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program Free
Japanese Journal of Clinical Oncology, Volume 49, Issue 11, November 2019, Page 1067, https://doi.org/10.1093/jjco/hyz143
Published: 06 November 2019
Journal Article
Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up Open Access
Japanese Journal of Clinical Oncology, Volume 50, Issue 1, January 2020, Pages 12–19, https://doi.org/10.1093/jjco/hyz132
Published: 21 October 2019
Journal Article
Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program Get access
Japanese Journal of Clinical Oncology, Volume 49, Issue 8, August 2019, Pages 772–779, https://doi.org/10.1093/jjco/hyz054
Published: 12 April 2019
Journal Article
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study Get access
Japanese Journal of Clinical Oncology, Volume 49, Issue 6, June 2019, Pages 506–514, https://doi.org/10.1093/jjco/hyz026
Published: 22 February 2019
Journal Article
Active heavy cigarette smoking is associated with poor survival in Japanese patients with advanced renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association Get access
Japanese Journal of Clinical Oncology, Volume 47, Issue 12, December 2017, Pages 1162–1169, https://doi.org/10.1093/jjco/hyx129
Published: 08 November 2017
Journal Article
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study Open Access
Japanese Journal of Clinical Oncology, Volume 47, Issue 7, July 2017, Pages 639–646, https://doi.org/10.1093/jjco/hyx049
Published: 13 April 2017
Journal Article
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial Open Access
Japanese Journal of Clinical Oncology, Volume 47, Issue 6, June 2017, Pages 551–559, https://doi.org/10.1093/jjco/hyw194
Published: 01 March 2017
Journal Article
Post hoc analysis of Japanese patients from the placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naive, metastatic castration-resistant prostate cancer—updated results Open Access
Japanese Journal of Clinical Oncology, Volume 47, Issue 3, March 2017, Pages 262–264, https://doi.org/10.1093/jjco/hyw187
Published: 21 December 2016
Journal Article
Clinical efficacy and prognostic factors of tumor progression in Japanese patients with advanced renal cell carcinoma treated with sorafenib Get access
Japanese Journal of Clinical Oncology, Volume 45, Issue 3, March 2015, Pages 274–280, https://doi.org/10.1093/jjco/hyu200
Published: 23 November 2014
Journal Article
A Case of Pneumocystis Pneumonia Associated with Everolimus Therapy for Renal Cell Carcinoma Get access
Japanese Journal of Clinical Oncology, Volume 43, Issue 5, May 2013, Pages 559–562, https://doi.org/10.1093/jjco/hyt019
Published: 18 February 2013
